07:00 , Jul 26, 2001 |  BC Extra  |  Financial News

De Novo raises EUR27.3 million

Molecular design play De Novo Pharmaceuticals ( Cambridge , U.K.) raised EUR27.3 million ($24 million) in a VC round led by Merlin Biosciences Fund, which put up EUR7.3 million. New investors included Life Science Partners;...
07:00 , Oct 19, 1998 |  BioCentury  |  Finance

Deja vu all over again

The two public companies that will emerge from NeXstar's proposed spin-off of its drug discovery assets will look quite similar to the two public companies that merged to create NXTR four years ago. NeXstar was...